Mark Gold, M.D.


Dr. Gold has served as a member of our Board of Directors since September 30, 2011 and Axogen Corporation’s board of directors since July 2007. From 1990 until his retirement in June 2014, Dr. Gold was a Professor at the University of Florida College of Medicine’s McKnight Brain Institute and was recognized as a Distinguished Professor, Eminent Scholar and was Chairman of the Department of Psychiatry. He was recognized as the 17th University of Florida Distinguished Alumni Professor and served in that capacity for four years. Dr. Gold taught neuroanatomy and medical neuroscience for four decades and has been a pioneer in translational neuroscience research. Throughout his career, he has been a consultant and senior advisor to banks, and to private equity and venture capital firms on medical devices, pharmaceuticals and health care services. Dr. Gold was a Founding Director of the Somerset Valley Bank and Somerset Valley Financial Services, Inc. (Nasdaq: SVBF) from 1991 to 1999 until its acquisition by Fulton Financial Corporation. He was also a Founding Director at Viewray, a public commercial stage MR-guided radiotherapy company specializing in cancer treatment. Dr. Gold is a Director of The Magstim Company Ltd., a United Kingdom based global leader in brain stimulation, and of Technomed, a Netherlands based global nerve modulation and intraoperative nerve monitoring company. Dr. Gold was trained in psychiatry at Yale University School of Medicine, earned his M.D. from the University of Florida College of Medicine and his bachelor’s degree from Washington University in St. Louis.